SCHEMBL2498828

SCHEMBL2498828

COc1ccc(I)cc1Br

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.52
TUBB1 Q9H4B7 2/20 0.46
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
HPGD P15428 1/20 0.44
CYP2C19 P33261 1/20 0.44
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
KMT2A Q03164 1/20 0.43
HTR2A P28223 1/20 0.43
MAPT P10636 5/20 0.42
MAPK1 P28482 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
POLB P06746 2/20 0.40
HTT P42858 1/20 0.40
MCOLN3 Q8TDD5 1/20 0.40
TP53 P04637 1/20 0.40
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL629513 0.82 MAPT (0.46) ALDH1A1HTR2AMAPTNPSR1L3MBTL1
SCHEMBL29426958 0.82 MAPT (0.46) ALDH1A1HTR2AMAPTNPSR1L3MBTL1
SCHEMBL31277237 0.78 CA2 (0.54) ALDH1A1TUBB1CYP1A2CYP2C19MAPK1
SCHEMBL470124 0.78 CA2 (0.54) ALDH1A1TUBB1CYP1A2CYP2C19MAPK1
SCHEMBL23143212 0.78 L3MBTL1 (0.39) ALDH1A1CYP1A2CYP2D6HPGDCYP2C19
SCHEMBL29887133 0.78 L3MBTL1 (0.39) ALDH1A1CYP1A2CYP2D6HPGDCYP2C19
SCHEMBL6113174 0.77 XDH (0.38) ALDH1A1CYP1A2CYP2C19LMNAHTR2A
SCHEMBL27988162 0.77 ALDH1A1 (0.34) ALDH1A1TUBB1HTR2AMAPK1L3MBTL1
SCHEMBL28986269 0.77 L3MBTL1 (0.48) ALDH1A1CYP1A2CYP2D6HPGDCYP2C19
SCHEMBL258418 0.76 CA12 (0.65) ALDH1A1TUBB1CYP1A2CYP2D6HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12629382-B2 Therapy VESTLANDETS INNOVASJONSSELSKAP AS (NO) 2026-05-19 US disclosed
US-12612424-B2 HPK1 inhibitors and uses thereof REGOR PHARMACEUTICALS, INC. (US) 2026-04-28 US disclosed
US-20260053393-A1 NEAR-IR GLUCOSE SENSORS PROFUSA INC (US) 2026-02-26 US disclosed
US-20250304535-A1 KAT6 Inhibitors BEIGENE SWITZERLAND GMBH (CH) 2025-10-02 US disclosed
WO-2025201504-A1 KAT6 INHIBITORS BEIGENE (SUZHOU) CO., LTD. (CN) 2025-10-02 WO disclosed
EP-4618755-A1 INHIBITORS AND DEGRADERS OF PIP4K PROTEIN Larkspur Biosciences, Inc. (US) 2025-09-24 EP disclosed
US-20250230174-A1 NEAR-IR GLUCOSE SENSORS PROFUSA, INC. (US) 2025-07-17 US disclosed
US-12285250-B2 Near-IR glucose sensors PROFUSA, INC (US) 2025-04-29 US disclosed
US-20250122152-A1 KAT6 Inhibitors BEIGENE SWITZERLAND GMBH (CH) 2025-04-17 US disclosed
WO-2025068943-A1 KAT6 INHIBITORS BEIGENE SWITZERLAND GMBH (CH) 2025-04-03 WO disclosed
CN-102203058-A Sulfur-linked compounds for the treatment of ophthalmic diseases and disorders ACUCELA INC 2011-09-28 CN disclosed
US-20110136843-A1 Novel Combination of Compounds to be Used in the Treatment of Airway Diseases, Especially Chronic Obstructive Pulmonary Disease (COPD) and Asthma ASTRAZENECA AB (SE) 2011-06-09 US disclosed
US-20100129471-A1 ISO CA-4 AND ANALOGUES THEREOF AS POTENT CYTOTOXIC AGENTS INHIBITING TUBULINE POLYMERIZATION CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) 2010-05-27 US disclosed
US-20100093865-A1 SULPHUR-LINKED COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS ACUCELA, INC. (US) 2010-04-15 US disclosed
WO-2010036640-A2 COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS SCHERING CORPORATION (US) 2010-04-01 WO disclosed
EP-2142493-A1 ISO CA-4 AND ANALOGUES THEREOF AS POTENT CYTOTOXIC AGENTS INHIBITING TUBULINE POLYMERISATION Centre National de la Recherche Scientifique (CNRS) (FR) 2010-01-13 EP disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed
WO-2008122620-A1 ISO CA-4 AND ANALOGUES THEREOF AS POTENT CYTOTOXIC AGENTS INHIBITING TUBULINE POLYMERISATION CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 2008-10-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250230174-A1 NEAR-IR GLUCOSE SENSORS IRS1, INSR, SLC2A4 ALDH1A1 3159/4885TUBB1 4017/4885CYP1A2 4561/4885
US-12612424-B2 HPK1 inhibitors and uses thereof NEK11, NEK1, CSNK1A1 ALDH1A1 3619/4885TUBB1 3269/4885CYP1A2 3048/4885
US-20260053393-A1 NEAR-IR GLUCOSE SENSORS INSR, IRS1, SLC2A4 ALDH1A1 3198/4885TUBB1 3736/4885CYP1A2 3737/4885
US-20250304535-A1 KAT6 Inhibitors KAT6A, KAT6B, KAT2A ALDH1A1 2832/4885TUBB1 308/4885CYP1A2 2457/4885
US-20100129471-A1 ISO CA-4 AND ANALOGUES THEREOF AS POTENT CYTOTOXIC AGENTS INHIBITING TUBULINE POLYMERIZATION TUBB4A, TUBA4A, TUBB4B ALDH1A1 2264/4885TUBB1 6/4885CYP1A2 1711/4885
US-12629382-B2 Therapy NR3C1, MGMT, GRM3 ALDH1A1 338/4885TUBB1 621/4885CYP1A2 1041/4885
US-20250122152-A1 KAT6 Inhibitors KAT6A, KAT6B, KAT7 ALDH1A1 3555/4885TUBB1 185/4885CYP1A2 3644/4885
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 ALDH1A1 2628/4885TUBB1 3658/4885CYP1A2 804/4885
US-12285250-B2 Near-IR glucose sensors IRS1, SLC2A4, GPR119 ALDH1A1 1177/4885TUBB1 3239/4885CYP1A2 2653/4885
US-20100093865-A1 SULPHUR-LINKED COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS ALDH1A2, MPST, CLN6 ALDH1A1 314/4885TUBB1 2002/4885CYP1A2 4705/4885
US-20110136843-A1 Novel Combination of Compounds to be Used in the Treatment of Airway Diseases, Especially Chronic Obstructive Pulmonary Disease (COPD) and Asthma CCR1, CCR5, CCR3 ALDH1A1 683/4885TUBB1 1381/4885CYP1A2 2453/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.